IPP Bureau
Bartronics India acquires 15% stake in Huwel Life Sciences for Rs. 50 Cr
By IPP Bureau - September 26, 2025
BIL also holds an option to increase its equity stake by an additional 15%
FDA approves Alembic’s Paroxetine ER tablets
By IPP Bureau - September 26, 2025
Paroxetine Extended-Release Tablets USP, 25 mg and 37.5 mg, are indicated for the treatment of major depressive disorder
_LOGO.jpg "DMMA warns regulatory burden threatening Gujarat’s pharma MSMEs"){kind=logo}
DMMA warns regulatory burden threatening Gujarat’s pharma MSMEs
By IPP Bureau - September 26, 2025
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
FUJIFILM India installs DR X-ray system at CHC Dholera
By IPP Bureau - September 26, 2025
The CSR initiative will offer Digital Radiology X-Ray service to Dholera and 33 surrounding villages in the region
Pi Health to deliver clinical research services for GSK’s Phase 2 oncology trial
By IPP Bureau - September 26, 2025
Physician-led Pi Health has demonstrated capabilities to dramatically reduce clinical trial timelines and administrative burden, while increasing data quality
Croda expanded UK facility, invests in biopharma innovation
By IPP Bureau - September 26, 2025
The expansion, supported by a significant UK government grant, includes a new lipid system synthesis facility and enhanced R&D capabilities
Lupin receives FDA tentative approval for Bictegravir, Emtricitabine, and Tenofovir Alafenamide tablets
By IPP Bureau - September 25, 2025
Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets are indicated for the treatment of human immunodeficiency virus infection in adults and pediatric patients weighing at least 25 kg
Evonik launches MaxiPure Polysorbate 80 for injectable drug formulations
By IPP Bureau - September 25, 2025
Ultra-high purity surfactant for biologics and parenteral drug formulations
Briefs: Relonchem, Patel Chem Specialities and J & H Pharma Consultants
By IPP Bureau - September 24, 2025
Relonchem receives marketing authorization for Moxonidine tablets
Shelter Pharma installs 15 KW solar power plant
By IPP Bureau - September 24, 2025
Alkem launches pertuzumab biosimilar ‘Pertuza’ for treatment of HER2-positive breast cancer
By IPP Bureau - September 24, 2025
Alkem's Pertuza is an affordable, indigenously-developed and manufactured biosimilar of pertuzumab
Zydus, Pinkathon to drive awareness on breast cancer across India
By IPP Bureau - September 24, 2025
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
Dr. Reddy's receives positive CHMP opinion from EMA for denosumab 'AVT03'
By IPP Bureau - September 24, 2025
Prolia is a prescription medicine used to treat osteoporosis in women
Max Hospital, Saket pioneers India’s first HDF certification program for Nephrologists
By IPP Bureau - September 24, 2025
